Home  »  Companies   »  Is Amedisys Inc. (AMED) a Keeper?...

Is Amedisys Inc. (AMED) a Keeper?

Amedisys Inc. (NASDAQ:AMED) went up by 8.05% from its latest closing price compared to the recent 1-year high of $179.91. The company’s stock price has collected 10.73% of gains in the last five trading sessions.

Is It Worth Investing in Amedisys Inc. (NASDAQ :AMED) Right Now?

Amedisys Inc. (NASDAQ:AMED) scored a price-to-earnings ratio above its average ratio, recording 25.03 x from its present earnings ratio. Plus, the 36-month beta value for AMED is at 0.97. Opinions of the stock are interesting as 8 analysts out of 15 who provided ratings for Amedisys Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 5 rated it as “hold,” and 1 as “sell.”

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

The average price from analysts is $115.85, which is $23.35 above the current price. AMED currently public float of 31.91M and currently shorts hold a 5.13% ratio of that float. Today, the average trading volume of AMED was 454.60K shares.

AMED’s Market Performance

AMED stocks went up by 10.73% for the week, with a monthly jump of 10.08% and a quarterly performance of -3.72%, while its annual performance rate touched -36.98%. The volatility ratio for the week stands at 5.43% while the volatility levels for the past 30 days are set at 3.96% for Amedisys Inc. The simple moving average for the period of the last 20 days is 11.69% for AMED stocks with a simple moving average of -16.82% for the last 200 days.

Analysts’ Opinion of AMED

UBS, on the other hand, stated in their research note that they expect to see AMED reach a price target of $95, previously predicting the price at $145. The rating they have provided for AMED stocks is “Sell” according to the report published on August 02nd, 2022.

Stifel gave a rating of “Hold” to AMED, setting the target price at $128 in the report published on June 29th of the previous year.

AMED Trading at 7.72% from the 50-Day Moving Average

After a stumble in the market that brought AMED to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -48.59% of loss for the given period.

Volatility was left at 3.96%, however, over the last 30 days, the volatility rate increased by 5.43%, as shares surge +9.14% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +7.23% upper at present.

During the last 5 trading sessions, AMED rose by +10.73%, which changed the moving average for the period of 200-days by -46.31% in comparison to the 20-day moving average, which settled at $83.21. In addition, Amedisys Inc. saw 10.73% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at AMED starting from Bohnert Denise M., who sale 557 shares at the price of $115.00 back on Jun 23. After this action, Bohnert Denise M. now owns 11,850 shares of Amedisys Inc., valued at $64,055 using the latest closing price.

Kemmerly David L, the of Amedisys Inc., sale 2,500 shares at $177.31 during a trade that took place back on Mar 29, which means that Kemmerly David L is holding 16,336 shares at $443,285 based on the most recent closing price.

Stock Fundamentals for AMED

Current profitability levels for the company are sitting at:

  • +11.12 for the present operating margin
  • +42.90 for the gross margin

The net margin for Amedisys Inc. stands at +9.44. Equity return is now at value 12.40, with 6.20 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 0.95.